J. Kurreck
Molecular Biology · 2003–2004
A researcher in the Science corpus: 2 papers; trusts 12 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 24 citations into it; #13,080 of 17,773 by trust here, #14,833 by citations
- Cancer Research — 11 citations into it
- Genetics — 10 citations into it
Whom J. Kurreck trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- T. Brummelkamp
- René Bernards
- Guangchao Sui
- Reuven Agami
- J. Heasman
- S. DeRuiter
- Michael T. McManus
- Sayda M. Elbashir
- E. Affar
Who trusts J. Kurreck overall
Papers from J. Kurreck's perspective
Ordered by how strongly the researchers J. Kurreck trusts endorse each paper. Same corpus, a different order for every researcher.
- A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (Science)
- A DNA vector-based RNAi technology to suppress gene expression in mammalian cells (Proceedings of the National Academy of Sciences of the United States of America)
- Stable suppression of tumorigenicity by virus-mediated RNA interference. (Cancer Cell)
- Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells (Nature Biotechnology)
- ATP requirements and small interfering RNA structure in the RNA interference pathway. (Cell)
- RNA interference targeting Fas protects mice from fulminant hepatitis (Nature Medicine)
- Analysis of gene function in somatic mammalian cells using small interfering RNAs. (Methods)
- RNA interference is mediated by 21- and 22-nucleotide RNAs. (Genes & Development)
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Gene silencing in mammals by small interfering RNAs (Nature reviews genetics)
Their papers
- Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells (2004) — 391 citations
- Antisense technologies. Improvement through novel chemical modifications. (2003) — 1,035 citations